BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 31490085)

  • 21. Cumambrin A prevents OVX-induced osteoporosis
    Zhou L; Liu Q; Hong G; Song F; Zhao J; Yuan J; Xu J; Tan RX; Tickner J; Gu Q; Xu J
    FASEB J; 2019 Jun; 33(6):6726-6735. PubMed ID: 30807230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycyrrhizin Suppresses RANKL-Induced Osteoclastogenesis and Oxidative Stress Through Inhibiting NF-κB and MAPK and Activating AMPK/Nrf2.
    Li Z; Chen C; Zhu X; Li Y; Yu R; Xu W
    Calcif Tissue Int; 2018 Sep; 103(3):324-337. PubMed ID: 29721581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4-Octyl itaconate attenuates LPS-induced acute kidney injury by activating Nrf2 and inhibiting STAT3 signaling.
    Xu L; Cai J; Li C; Yang M; Duan T; Zhao Q; Xi Y; Sun L; He L; Tang C; Sun L
    Mol Med; 2023 Apr; 29(1):58. PubMed ID: 37095432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of Keap1-Nrf2 signaling by 4-octyl itaconate protects human umbilical vein endothelial cells from high glucose.
    Tang C; Tan S; Zhang Y; Dong L; Xu Y
    Biochem Biophys Res Commun; 2019 Jan; 508(3):921-927. PubMed ID: 30545629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.
    Chen G; Xu Q; Dai M; Liu X
    Biochem Biophys Res Commun; 2019 Feb; 509(2):329-334. PubMed ID: 30579598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis
    Yang J; Tang R; Yi J; Chen Y; Li X; Yu T; Fei J
    FASEB J; 2019 Jun; 33(6):7261-7273. PubMed ID: 30857415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4-Octyl itaconate suppresses the osteogenic response in aortic valvular interstitial cells via the Nrf2 pathway and alleviates aortic stenosis in mice with direct wire injury.
    Peng X; Su S; Zeng J; Xie K; Yang X; Xian G; Xiao Z; Zhu P; Zheng S; Xu D; Zeng Q
    Free Radic Biol Med; 2022 Aug; 188():404-418. PubMed ID: 35787451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-Octyl Itaconate Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting Oxidative Stress and Inflammation.
    Li Y; Chen X; Zhang H; Xiao J; Yang C; Chen W; Wei Z; Chen X; Liu J
    Drug Des Devel Ther; 2020; 14():5547-5558. PubMed ID: 33364751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-octyl Itaconate inhibits lipopolysaccharide (LPS)-induced osteoarthritis via activating Nrf2 signalling pathway.
    Zhang Q; Bai X; Wang R; Zhao H; Wang L; Liu J; Li M; Chen Z; Wang Z; Li L; Wang D
    J Cell Mol Med; 2022 Mar; 26(5):1515-1529. PubMed ID: 35068055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bu-Shen-Ning-Xin decoction: inhibition of osteoclastogenesis by abrogation of the RANKL-induced NFATc1 and NF-κB signaling pathways via selective estrogen receptor α.
    Wang L; Qiu XM; Gui YY; Xu YP; Gober HJ; Li DJ
    Drug Des Devel Ther; 2015; 9():3755-66. PubMed ID: 26229438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-κB signaling pathway.
    Zheng L; Gao J; Jin K; Chen Z; Yu W; Zhu K; Huang W; Liu F; Mei L; Lou C; He D
    FASEB J; 2019 Jun; 33(6):7667-7683. PubMed ID: 30893559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methyl 3,4-dihydroxybenzoate inhibits RANKL-induced osteoclastogenesis via Nrf2 signaling
    Huang Z; Jiang Z; Zheng Z; Zhang X; Wei X; Chen J; Zhao F
    Acta Biochim Biophys Sin (Shanghai); 2022 Aug; 54(8):1068-1079. PubMed ID: 35929596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
    Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S
    Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis.
    Kim M; Kim HS; Kim JH; Kim EY; Lee B; Lee SY; Jun JY; Kim MB; Sohn Y; Jung HS
    BMC Complement Med Ther; 2020 Feb; 20(1):35. PubMed ID: 32024503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic.
    Liu Z; Hou Y; Li L; Yang Y; Jia J; Hong Z; Li T; Xu Y; Fu J; Sun Y; Yamamoto M; Wang H; Pi J
    Toxicol Appl Pharmacol; 2019 Mar; 367():62-70. PubMed ID: 30742845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The naturally derived small compound Osthole inhibits osteoclastogenesis to prevent ovariectomy-induced bone loss in mice.
    Zhao D; Wang Q; Zhao Y; Zhang H; Sha N; Tang D; Liu S; Lu S; Shi Q; Zhang Y; Dong Y; Wang Y; Shu B
    Menopause; 2018 Dec; 25(12):1459-1469. PubMed ID: 29944638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Itaconate prevents abdominal aortic aneurysm formation through inhibiting inflammation via activation of Nrf2.
    Song H; Xu T; Feng X; Lai Y; Yang Y; Zheng H; He X; Wei G; Liao W; Liao Y; Zhong L; Bin J
    EBioMedicine; 2020 Jul; 57():102832. PubMed ID: 32574955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probucol suppresses osteoclastogenesis via activating Nrf2 signaling and ameliorates ovariectomy-induced bone loss.
    Guo J; Ren R; Guo Z; Sun K; He J; Shao J; Wang X
    Int Immunopharmacol; 2023 Mar; 116():109820. PubMed ID: 36758295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.
    Sakai E; Aoki Y; Yoshimatsu M; Nishishita K; Iwatake M; Fukuma Y; Okamoto K; Tanaka T; Tsukuba T
    Phytomedicine; 2016 Jul; 23(8):828-37. PubMed ID: 27288918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.